Outcome of Board Meeting
Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, has transacted the following:-"1. The Board has deferred the Agenda relating to approval of the Audited financial statements for the year ended March 31, 2015 in view of disagreement with the statutory auditors with regard to reporting in the consolidated financial statements regarding accounting of employee...